We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Atlantic Lithium Limited | LSE:ALL | London | Ordinary Share | AU0000237554 | ORD NPV (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.45 | 2.25% | 20.45 | 20.45 | 20.50 | 20.50 | 19.94 | 20.45 | 710,032 | 16:28:57 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Iron Ores | 0 | -12.19M | -0.0200 | -10.23 | 124.59M |
Date | Subject | Author | Discuss |
---|---|---|---|
15/12/2009 22:58 | WJCCGHCC, I must have missed that. There was an update about the acquisition of TimeCare on the 27 but the quater did not finish until the end of November. Can you provide a link to the numbers? Thanks. | king_roster_iii | |
15/12/2009 20:09 | Do you mean contract wins? They've already updated on current trading on 27/11. | wjccghcc | |
15/12/2009 19:33 | A buy today of 20,000. Lets hope some one knows something and the interims are in excess of £8 million. But if we dont get an announcement this week it will be disappointing and potentially worrying. It is true that Bowles and Scandrett have been out in Sweden sorting out the TimeCare deal but what has Simon Thorne, the FD, been doing? If the company sets up expectations of timely quaterly reporting then they should live up to them. | king_roster_iii | |
14/12/2009 10:29 | The Board of Allocate is pleased to announce that at the General Meeting of its Shareholders held at 9.30 a.m. today, the Resolutions, as set out in the Notice of General Meeting sent to Shareholders on 27 November 2009, were duly passed without amendment. | jakleeds | |
30/11/2009 16:49 | Quite right. I had meant to say lower eps. The difference might, as you say, purely be the envisaged tax charge (I'm afraid I had not looked at that in detail and had thought they still had losses carried forward). It cannot allow for new shares. The deal is not done yet and with those figures no uplift is shown at the pretax level. My take is that would be a pro rata calculation ie a number of months on a old basis and a number of months on an new enlarged capital basis divided into the attributable after tax profits.The eps then reflecting only the period of ownership. Swedish corporate tax,of course,is generally a lot higher than in the UK. | gregmorg | |
30/11/2009 14:26 | They're not. They're forecasting PBT increasing from 3.11mm to 4.52mm. They are forecasting lower EPS but I think that's more of them moving to a normal tax rate plus the increased number of shares after the placing. | wjccghcc | |
30/11/2009 12:24 | Detailed Broker Forecasts 2010 2011 Broker Date Rec Pre-tax (£) EPS(£p) DPS(£p) Pre-tax(£) EPS(£p) DPS(£p) Numis Securities... 27-11-09 BUY 3.11 5.66 4.52 5.16 Edison Investmen... 06-10-09 None 2.95 4.60 3.66 5.70 According to this service the Co Broker is now forecasting lower profits going forward! This excludes the acquisition as the date of this submission shows and its not done yet either. The acquisition looks good and its also good to see the statement "significantly enhancing eps". The acquisition's growth pattern over the last couple of years seems a bit indifferent and this year it has a "lower run rate". No doubt they can develop a few synergies even though it will still be run as a separate co. Maybe the revenue momentum eased as the top guys were involved in other negotiations. It is good to see the market cap being bulked up as size widens the institutional base. As can be seen, Edison has different numbers but I have the impression that they are usually paid by the Co to complete a research report. Nothing wrong in that especially when a Co feels there is minimal research out in the market place. | gregmorg | |
30/11/2009 10:36 | Nice start this morning. Of course the placing will help boost the stock's liquidity which has been a problem and has been holding the price back. This reminds me more and more of Torex a few years ago. | jakleeds | |
28/11/2009 16:00 | Hi All I'm sure you all noticed the trading update within the Placing document.. Current trading The Directors believe that the Company continues to make significant progress despite the current economic climate. Allocate continues to expand its addressable markets both within the UK and overseas. In addition, the Company's recent announcement (on 17 November 2009) of a strategic partnership with NHS Professionals to deliver long-term fully integrated workforce management services to NHS organisations reinforces Allocate's position within the e-Rostering market for Healthcare in the UK. As a result, the Directors are confident that the Company's performance for the full year will be in line with their expectations. Of course, Allocate usually provide a quarterly update on Contract Wins, this is due early December. I look forward to further solid progress. Regards Rob P.s because of the raising tax charge its difficult to get an accurate eps forecast but the underlying business is growing strongly which is of most importance. | robward | |
27/11/2009 10:35 | New areticle by Proactiveinvestors.c | andy | |
27/11/2009 09:15 | Looking good I understand Numis have increased their price target to 84p from 74p. | the shuffle man | |
27/11/2009 07:33 | good move. long term value. not disgracefull dicount. | odvod | |
27/11/2009 07:24 | Acquisition looks rather exciting!! The Acquisition is currently expected by the Directors to be significantly earnings enhancing in the first full financial year of ownership by Allocate. "Our business strategy for the healthcare sector is to be the leading supplier of workforce optimisation solutions in Europe. The acquisition of Time Care gives us a solid position in the Nordic region. Furthermore, the self-rostering application from Time Care is seen as a key addition to our existing workforce optimisation portfolio. "We are delighted with the support that we have received for the Placing and Acquisition from both our existing shareholders and from new investors, which resulted in the Placing being substantially oversubscribed." Leendert Venema, CEO of Time Care, said: "The strategic fit between Allocate and Time Care is excellent for both customers and staff. The enlarged group is now one of the leading providers of workforce management software for the healthcare sector in Europe. Healthcare is rapidly emerging as one of the most exciting areas of the workforce management software market and the enlarged group is well positioned to exploit this opportunity. We look forward to contributing to Allocate's continued strong growth." | jakleeds | |
19/11/2009 22:35 | Hi Rob. Both broker forecasts (Numis and Edison) have been embargoed, on the 16th and 17th November respectively. Watch this space Regards | jakleeds | |
19/11/2009 11:00 | There is caution and "caution". It strikes me that this is a very small market cap company with a limited following as a result. For most institutional funds it is below their criteria. The only profit forecast is from the "shop" and even that shows expectations of a minimal increase on last year. That caution possibly tells one that the visibility is not there. That is what the broker forcast tells me. If this is so then then the company's rating will remain low to reflect that. High PE valuations mostly apply to acknowledged growth companies and one can easily see the envisaged profits growth within the forecasts. Maybe this one grows and its following increases but only time will tell. As a shareholder from the very beginning of life as a plc it would be pleasant, after many tribulations early on, to see greater recognition of what looks like a potentially very interesting company. Trouble is so many small ones stumble or get taken out after only partial recognition. | gregmorg | |
18/11/2009 23:31 | Hi Jak It would be unusual for a broker upgrade so early in the Financial Year. The Board are always very cautious and even if the Interim Results were impressive, you can rest assured the usual "the Directors are confident that the company's performance for the full year will be in line with their expectations" will be trotted out !. Allocate are a super company which you can pop in the pension and sleep easy. Of course, I am happy to be proven wrong. Regards Rob | robward | |
18/11/2009 23:19 | Probably a broker upgrade, time will tell | jakleeds | |
18/11/2009 18:04 | Delayed reaction to the good news? Thus probably not many watching this share. Not many shares traded today either. Any press mentions? | bostonborn | |
18/11/2009 13:06 | That's better finally beginning to move. | jakleeds | |
17/11/2009 18:24 | Good news today but suprisingly the share price doesn't budge today. That's life I suppose! | bostonborn | |
17/11/2009 09:32 | More good news: | jakleeds | |
05/11/2009 23:05 | Thanks King_roster_III. | jakleeds | |
05/11/2009 17:54 | Just come back from the annual conference thrown by NHS Employers. Allocate demonstrated their new expenses module there. There was a lot of buzz around their stand. Just as the NHS is begining to tighten their belts allocate seem to be developing just the right software to continue helping Trusts save costs. | king_roster_iii | |
30/10/2009 15:22 | "The partnership between ourselves and Allocate Software to complete their e-Expenses solution is a significant initiative. The company already provide e-Rostering and Bank management solutions within our region and so the e-Expenses initiative is an obvious next step building on the platform already in place. Particularly significant will be leveraging the existing ESR interfaces to ensure accurate payment and reduction in both paperwork and administration" David Pickworth, Payroll Project Manager, Kent and Medway NHS Payroll Services | jakleeds |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions